Denali Therapeutics Inc. - DNLI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$2.398B
QoQ value delta ($000)
+$446.9M (+22.9%)
Implied price effect (QoQ)
+13.72%
Shares
Total shares
145,240,005
QoQ shares delta
+10,855,564 (+8.08%)
Total shares held by funds (by quarter)

Market chart (DNLI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 23 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 215,585 13,057,890 0.0%
BlackRock, Inc. 209,927 12,715,201 0.0%
BAILLIE GIFFORD & CO 203,252 12,310,889 0.17%
Temasek Holdings (Private) Ltd 115,784 7,012,974 0.37%
STATE STREET CORP 103,408 6,263,371 0.0%
FMR LLC 100,664 6,097,211 0.01%
NORGES BANK 84,524 5,119,622 0.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 82,281 4,983,726 0.02%
PRICE T ROWE ASSOCIATES INC /MD/ 64,654 3,915,951 0.01%
GOLDMAN SACHS GROUP INC 63,329 3,835,803 0.01%
BAKER BROS. ADVISORS LP 61,610 3,731,695 0.36%
Capital Research Global Investors 61,569 3,729,244 0.01%
ALLIANCEBERNSTEIN L.P. 58,741 3,557,935 0.02%
GEODE CAPITAL MANAGEMENT, LLC 57,104 3,458,131 0.0%
Holocene Advisors, LP 52,051 3,152,734 0.11%
Crestline Management, LP 46,405 2,810,732 87.02%
Fisher Asset Management, LLC 42,751 2,589,403 0.01%
UBS Group AG 39,701 2,404,704 0.01%
DIMENSIONAL FUND ADVISORS LP 39,198 2,374,303 0.01%
Aberdeen Group plc 33,564 2,032,967 0.05%
Casdin Capital, LLC 30,378 1,840,000 1.89%
Lynx1 Capital Management LP 28,706 1,738,750 5.81%
Point72 Asset Management, L.P. 28,067 1,700,000 0.03%
PRINCIPAL FINANCIAL GROUP INC 25,163 1,524,123 0.01%
Siren, L.L.C. 23,056 1,396,513 0.69%